10-K: Select Medical Holdings Corporation Reports 2023 Financial Results and Announces Concentra Separation

Select Medical Holdings Corporation files its 10-K report for the year ended December 31, 2023, detailing financial performance and announcing the planned separation of its Concentra business.

Summary

• Select Medical Holdings Corporation reported a revenue of $6,664.1 million for the year ended December 31, 2023.
• The company's revenue was distributed across its segments with approximately 35% from critical illness recovery hospitals, 15% from rehabilitation hospitals, 18% from outpatient rehabilitation, and 28% from Concentra.
• Net income for 2023 was $299.7 million, a significant increase compared to $198.0 million in 2022.
• The company plans to separate its Concentra business into a new publicly traded company by the end of fiscal year 2024.
• The average length of stay for patients in critical illness recovery hospitals was 31 days, and 14 days for rehabilitation hospitals in 2023.

Sentiment

Score: 7

Explanation: The document presents a generally positive outlook with improved financial results and strategic initiatives, but also acknowledges risks and challenges. The planned separation of Concentra is a significant strategic move.

Positives

• The company experienced a significant increase in net income in 2023 compared to 2022.
• The critical illness recovery hospital segment showed a substantial improvement in Adjusted EBITDA.
• The company's revenue increased across all segments.
• The company has a strong cash flow and a track record of improving financial performance.
• The company has a significant scale and experience in completing and integrating acquisitions.

Negatives

• The company experienced a loss on early retirement of debt of $14.7 million in 2023.
• The company is exposed to fluctuating market conditions, including rising interest rates.
• The company faces labor shortages and increased employee-related costs.
• The company is subject to extensive government regulations and changes in reimbursement policies.
• The company is subject to post-payment reviews of claims which may require repayment of amounts already paid.

Risks

• Changes in Medicare reimbursement rates or methods could reduce revenue and profitability.
• Adverse economic conditions, including inflation, could increase operating costs and negatively impact financial results.
• Labor shortages and increased employee turnover could lead to higher operating costs.
• Public health threats, such as pandemics, could disrupt operations and financial performance.
• The company faces competition from other healthcare providers.
• The company's substantial indebtedness may limit cash flow available for investments.
• The company is subject to risks associated with cyber security breaches.
• The company may be adversely affected by negative publicity.

Future Outlook

The company intends to separate its Concentra business into a new publicly traded company by the end of fiscal year 2024, subject to certain conditions. The company also plans to pursue growth through acquisitions and joint ventures.

Management Comments

• The company's management believes that the presentation of Adjusted EBITDA is important to investors because it is commonly used as an analytical indicator of performance within the healthcare industry.
• Management believes that the company is well-positioned to benefit from the rising demand for medical services due to an aging population in the United States.

Industry Context

The healthcare industry is highly regulated and competitive, with providers facing pressure to control costs and improve quality. Select Medical operates in multiple segments of the post-acute care market, which is experiencing increasing demand due to an aging population and the need for specialized care.

Comparison to Industry Standards

• The company's performance is compared to other large operators of similar facilities, such as ScionHealth and Encompass Health Corporation.
• The company's outpatient rehabilitation clinics face competition from physician-owned clinics, locally managed clinics, and national providers like Athletico Physical Therapy, ATI Physical Therapy, U.S. Physical Therapy, and Upstream Rehabilitation.
• The company's Concentra segment competes with independent physicians, hospital emergency departments, and hospital-owned facilities.

Management Changes

Legal Proceedings

• The company is involved in various legal actions, proceedings, and claims in the ordinary course of business.
• The company is cooperating with investigations by the U.S. Attorneys Office for the Western District of Oklahoma, the U.S. Department of Justice, and the California Department of Insurance.
• The company is a defendant in a class action lawsuit related to a data breach at a third-party vendor.

Related Party Transactions

• The company leases its corporate headquarters from companies owned by a related party.
• The company provides management and employee leasing services to related parties affiliated through its equity method investments.

Stakeholder Impact

• Shareholders may experience changes in the value of their investment due to the planned separation of Concentra.
• Employees may be affected by the organizational changes resulting from the Concentra separation.
• Patients may experience changes in service delivery as the company adapts to market conditions and regulatory changes.
• Payors may see changes in reimbursement rates and contract terms.
• Suppliers may be affected by changes in the company's purchasing patterns.

Next Steps

• The company will proceed with the planned separation of its Concentra business.
• The company will continue to pursue growth through acquisitions and joint ventures.
• The company will focus on improving operating efficiency and controlling costs.

Key Dates

Keywords

Select Medical, Critical Illness Recovery Hospitals, Rehabilitation Hospitals, Outpatient Rehabilitation, Concentra, Medicare, Financial Results, Healthcare, Acquisitions, Separation, Occupational Health, 10-K